Genovate Biotechnology Co., Ltd. (TPEX:4130)

Taiwan · Delayed Price · Currency is TWD

32.60

-0.60 (-1.81%)

Mar 4, 2026, 10:49 AM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals			528.51M	438.76M	434.25M	472.72M	465.76M
Pharmaceuticals Growth			20.46%	1.04%	-8.14%	1.50%	2.18%
Total			528.51M	438.76M	434.25M	472.72M	465.76M
Total Growth			20.46%	1.04%	-8.14%	1.50%	2.18%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan			519.35M	435.22M	429.86M	467.03M	459.28M
Taiwan Growth			19.33%	1.25%	-7.96%	1.69%	2.90%
Other			9.16M	3.54M	4.40M	5.69M	6.48M
Other Growth			158.64%	-19.48%	-22.70%	-12.19%	-31.61%
Total			528.51M	438.76M	434.25M	472.72M	465.76M
Total Growth			20.46%	1.04%	-8.14%	1.50%	2.18%

Source: S&P Global Market Intelligence.